Our Pricing

Published on: June 03, 2026

Seeking a mounjaro nhs alternative uk pharmacy for weight management? Cured Pharmacy provides private access to genuine UK-licensed Mounjaro (tirzepatide) from £124.99 with transparent pricing, free clinical consultations under 3 minutes, and discreet next-day delivery across the UK. While Mounjaro is not routinely available through NHS weight management services, our UK-registered clinical team can assess your suitability for private prescription treatment.

Why Patients Seek Mounjaro NHS Alternative Treatments

Currently, Mounjaro is not widely available through NHS weight management programmes, despite NICE guidance recommending tirzepatide for specific patient groups with obesity [1]. NHS provision remains limited due to budget constraints and strict eligibility criteria, prompting many UK patients to explore private pharmacy options for faster access.

Private prescription services through registered UK pharmacies like Cured Pharmacy offer an alternative pathway for patients who meet clinical criteria but face lengthy NHS waiting lists or fall outside current commissioning guidelines. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription meets MHRA standards and patient safety protocols.

The decision to pursue private treatment should consider both clinical suitability and financial commitment, as weight loss medications typically require sustained use over 12-24 months to achieve optimal results. All patients must complete a clinical assessment by a UK-registered prescriber before treatment can be dispensed.

How Mounjaro Works: The Science Behind Tirzepatide

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK by the MHRA [2]. This dual-action mechanism sets it apart from single-pathway treatments, activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously.

In the landmark SURPASS-3 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — significantly higher than comparator treatments [2]. The SURMOUNT-1 trial specifically examining tirzepatide for weight management demonstrated average reductions of up to 20.9% in adults with obesity but without diabetes [3].

Tirzepatide works by slowing gastric emptying, reducing appetite through central nervous system pathways, and improving insulin sensitivity. These combined effects help patients feel fuller longer whilst supporting metabolic health improvements including reductions in HbA1c, blood pressure, and lipid profiles [2][3].

Expected Timeline for Results

Most patients notice appetite reduction within the first 1-2 weeks of treatment, with measurable weight loss typically beginning around week 4. Clinical trials show progressive weight reduction over 72 weeks, with the majority of weight loss occurring in the first 36-48 weeks when combined with dietary modifications and increased physical activity [3].

Mounjaro vs Wegovy: Comparing GLP-1 Weight Loss Treatments

Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are injectable treatments licensed in the UK for chronic weight management, but they differ in mechanism and clinical outcomes. Wegovy activates only GLP-1 receptors, whilst Mounjaro's dual GIP/GLP-1 action produces enhanced metabolic effects in head-to-head comparisons [4].

The SURPASS-2 trial directly compared tirzepatide against semaglutide 1mg in patients with type 2 diabetes, showing superior weight reduction with tirzepatide across all dose levels [4]. However, Wegovy remains an excellent option for many patients, particularly those seeking effective treatment at a lower entry price point.

Your choice between treatments should be guided by your UK prescriber's clinical assessment, considering your medical history, weight loss goals, tolerance to side effects, and budget. Both medications require once-weekly subcutaneous injection and work best alongside lifestyle modifications including reduced calorie intake and regular physical activity.

Side Effect Profiles

Both tirzepatide and semaglutide commonly cause gastrointestinal side effects including nausea, diarrhoea, vomiting, and constipation, particularly during dose escalation phases [2][4]. These effects typically diminish over 4-8 weeks as the body adjusts. Starting with lower doses and gradually titrating upward helps minimise discomfort whilst maintaining treatment adherence.

Mounjaro Pricing and Treatment Costs at Cured Pharmacy

At Cured Pharmacy, Mounjaro treatment starts from £124.99 per pen, with transparent upfront pricing displayed before your clinical consultation. Unlike some providers who reveal costs only after assessment, we believe patients deserve complete price clarity from the outset.

Your final treatment cost depends on your prescribed maintenance dose, which your UK prescriber determines based on your response to treatment and weight loss progress. Mounjaro is available in five dose strengths (2.5mg, 5mg, 7.5mg, 10mg, and 15mg), with most patients titrating up gradually over 16-20 weeks to reach their optimal maintenance dose.

We guarantee the lowest prices in the UK for genuine, UK-licensed weight loss medications. Every Mounjaro pen dispensed by Cured Pharmacy comes directly from MHRA-approved suppliers, ensuring authenticity and proper cold-chain storage. All prescription medications include free delivery in discreet, unmarked packaging.

Who Can Access Mounjaro Through Private Prescription

Mounjaro is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea [1]. Your UK prescriber will calculate your BMI and review your medical history during the online consultation.

Certain medical conditions preclude Mounjaro use, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic ketoacidosis. Pregnant or breastfeeding women cannot use tirzepatide, and effective contraception is recommended for women of childbearing potential [2].

During your free consultation at Cured Pharmacy, our UK-registered prescribers assess your complete medical history, current medications, and weight loss goals to determine whether Mounjaro represents a safe and appropriate treatment option. If tirzepatide is not suitable, alternative weight management treatments may be recommended based on your individual clinical profile.

Pre-Treatment Health Checks

Before starting Mounjaro, your prescriber may recommend baseline health monitoring including blood pressure measurement, HbA1c testing (if diabetic or pre-diabetic), and lipid profile assessment. These measurements establish your starting point and help track metabolic improvements throughout treatment. Regular follow-up consultations ensure treatment remains safe and effective as you progress.

How to Start Your Mounjaro Treatment at Cured Pharmacy

Beginning your mounjaro nhs alternative treatment through Cured Pharmacy takes under 3 minutes. Click 'Start Assessment' on our Mounjaro product page to complete a confidential online questionnaire covering your medical history, current medications, weight loss goals, and any relevant health conditions.

A UK-registered prescriber reviews your consultation within hours (typically same-day on weekdays). If Mounjaro is deemed clinically appropriate, your prescription is sent directly to our dispensing team. We source all medications from MHRA-licensed UK suppliers and dispatch via tracked courier in completely discreet packaging with no pharmacy branding.

Your first Mounjaro pen will be the 2.5mg starter dose, which you'll use for 4 weeks before increasing to 5mg. This gradual titration schedule minimises gastrointestinal side effects whilst your body adjusts to treatment. Our clinical team remains available throughout your treatment journey for dosing questions, side effect management, and ongoing prescription renewals.

All follow-up prescriptions require a brief clinical review to assess your progress, tolerance, and any changes to your health status. We recommend monthly weight tracking and regular communication with your prescriber to optimise treatment outcomes and address any concerns promptly.

Scientific References

1. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating overweight and obesity [TA1026]. NICE. https://www.nice.org.uk/guidance/ta1026 [accessed 13 August 2026]
2. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2): a randomised, open-label, phase 3 trial. The Lancet, 398(10303), 701-713. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment, dietary modifications, and physical activity levels.